RHT Share Price

Open 0.03 Change Price %
High 0.03 1 Day 0.00 0.00
Low 0.03 1 Week 0.00 0.00
Close 0.03 1 Month 0.01 50.00
Volume 304500 1 Year 0.01 50.00
52 Week High 0.04
52 Week Low 0.01
RHT Important Levels
Resistance 2 0.03
Resistance 1 0.03
Pivot 0.03
Support 1 0.03
Support 2 0.03
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
TEG 0.05 0.00%
AKK 0.01 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
IMU 0.02 100.00%
IMU 0.02 100.00%
PMQ 0.03 50.00%
ARD 0.03 50.00%
ARD 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
EXG 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
AVD 0.01 -50.00%
SRX 16.00 -37.23%
SRX 16.00 -37.23%
More..

Resonance Health Ltd (ASX: RHT)

RHT Technical Analysis 3
As on 9th Dec 2016 RHT Share Price closed @ 0.03 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.03 & Buy for SHORT-TERM with Stoploss of 0.03 we also expect STOCK to react on Following IMPORTANT LEVELS.
RHT Target for December
1st Target up-side 0.02
2nd Target up-side 0.02
3rd Target up-side 0.02
1st Target down-side 0.02
2nd Target down-side 0.02
3rd Target down-side 0.02
RHT Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.resonancehealth.com
RHT Address
RHT
278 Stirling Highway
Ground Floor
Claremont, WA 6010
Australia
Phone: 61 8 9286 5300
Fax: 61 8 9286 1179
Interactive Technical Analysis Chart Resonance Health Ltd ( RHT ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Resonance Health Ltd
RHT Business Profile
Resonance Health Limited, a healthcare company, is engaged in the development and commercialization of magnetic resonance imaging (MRI) related technology for the diagnosis and management of human disease. The company’s principal product is FerriScan, a non-invasive liver diagnostic technology used for the measurement of iron in the liver. It is also developing imaging tools for the quantification of liver fat and liver fibrosis to address clinical need for patients with fatty liver disease and viral hepatitis. In addition, the company provides various core lab services to the pharmaceutical industry. It operates in Australia, the United Kingdom, Germany, and the United States, as well as provides its products and services through distributors in the Middle East and Turkey. Resonance Health Limited is headquartered in Claremont, Australia.